Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

CP-122288

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
CP-122288
Identifiers
  • N-methyl-1-[3-([(2R)-1-methylpyrrolidin-2-yl]methyl)-1H-indol-5-yl]methanesulfonamide
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC16H23N3O2S
Molar mass321.44 g·mol−1
3D model (JSmol)
  • CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)C[C@H]3CCCN3C
  • InChI=1S/C16H23N3O2S/c1-17-22(20,21)11-12-5-6-16-15(8-12)13(10-18-16)9-14-4-3-7-19(14)2/h5-6,8,10,14,17-18H,3-4,7,9,11H2,1-2H3/t14-/m1/s1
  • Key:BWQZTHPHLITOOZ-CQSZACIVSA-N

CP-122,288 is adrug of thepyrrolidinylmethylindole family which acts as a potent and selectiveagonist for the5-HT1B,5-HT1D and5-HT1Fserotonin receptor subtypes. It is a derivative of themigraine medicationsumatriptan, but while CP-122,288 is 40,000 times more potent than sumatriptan as an inhibitor of neurogenic inflammation and plasma protein extravasation, it is only twice as potent as a constrictor of blood vessels. In human trials, CP-122,288 was not found to be effective as a treatment for migraine, but its selectivity for neurogenic anti-inflammatory action over vasoconstriction has made it useful for research into the underlying causes of migraine.[1][2][3][4][5]

See also

[edit]

References

[edit]
  1. ^Lee WS, Moskowitz MA (October 1993). "Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater".Brain Research.626 (1–2):303–5.doi:10.1016/0006-8993(93)90591-a.PMID 8281439.S2CID 9350217.
  2. ^Beattie DT, Connor HE (April 1995). "The pre- and postjunctional activity of CP-122,288, a conformationally restricted analogue of sumatriptan".European Journal of Pharmacology.276 (3):271–6.doi:10.1016/0014-2999(95)00080-5.PMID 7601213.
  3. ^Waeber C, Moskowitz MA (September 1995). "[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study".Naunyn-Schmiedeberg's Archives of Pharmacology.352 (3):263–75.doi:10.1007/bf00168556.PMID 8584041.S2CID 8828017.
  4. ^Gupta P, Brown D, Butler P, Ellis P, Grayson KL, Land GC, et al. (November 1995)."The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation".British Journal of Pharmacology.116 (5):2385–90.doi:10.1111/j.1476-5381.1995.tb15084.x.PMC 1909056.PMID 8581273.
  5. ^Roon KI, Olesen J, Diener HC, Ellis P, Hettiarachchi J, Poole PH, Christianssen I, Kleinermans D, Kok JG, Ferrari MD (February 2000). "No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: results of two randomized, double-blind, placebo-controlled clinical trials".Annals of Neurology.47 (2):238–41.doi:10.1002/1531-8249(200002)47:2<238::AID-ANA15>3.0.CO;2-L.PMID 10665496.S2CID 41069269.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7


Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=CP-122288&oldid=1303294865"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp